Supira Medical logo

Supira Medical

Healthcare & Life Sciences

Recent Finacing

Series D

Recent Raise

$40M


Supira Medical, Inc. is developing the Supira System, a percutaneous ventricular assist device (pVAD) designed to provide hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients.

Total Funding

$40M

Headquarters

Los Gatos, USA

Founded

N/A

Focus Areas

Medical Device Development
Percutaneous Ventricular Assist Device
Hemodynamic Support
High-Risk Percutaneous Coronary Interventions
Cardiogenic Shock Treatment
Real-Time Pressure Measurements

Investors